Business Context and Reporting Period
This Form 8-K filing by InfuSystem Holdings, Inc. (Delaware) covers events occurring on May 18, 2017. The report details significant changes to the company's executive leadership and board composition.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Departure of CEO: Eric K. Steen ceased serving as President and Chief Executive Officer and resigned from the Board of Directors, effective immediately on May 18, 2017.
- Severance Package: Mr. Steen is entitled to a cash severance payment equal to 15 months of his base salary, target bonus amounts for the subsequent 12 months, and continuation of COBRA health benefits for 12 months. These payments are contingent upon the execution of a general release and continued performance of post-termination obligations.
- Leadership Appointment: Gregg Lehman, Ph.D., was appointed Executive Chairman and interim principal executive officer.
- Organizational Restructuring: The Board created an "Office of the President" to oversee strategic initiatives until a new CEO is appointed. This office includes Dr. Lehman, Director David Dreyer, and three executive vice presidents.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or specific risk factors. The primary contingency noted is that the severance payments to the departing CEO are conditional upon the execution of a release of claims and adherence to post-termination obligations. The company has initiated a search for a permanent Chief Executive Officer.
Investor Verification Checklist
- Verify the total financial impact of the 15-month severance package and accrued bonuses on the company's upcoming quarterly results.
- Confirm the timeline and criteria for the appointment of a permanent Chief Executive Officer.
- Review the press release (Exhibit 99.1) for additional strategic context regarding the leadership transition.
- Monitor subsequent filings for any changes to the Board of Directors or the composition of the Office of the President.